Table 2.
Characteristics | All Patients | Survivors | Non-Survivors | p-Value |
---|---|---|---|---|
n = 53 | n = 35 | n = 18 | ||
CRP (mg/L) | 277 (178–345) | 304 (174–341) | 210 (178–347) | 0.74 |
D-dimer (mg/L) | 2.48 (1.38–5.22) | 2.42 (1.18–3.96) | 3.86 (1.81–8.47) | 0.17 |
Ferritin (mg/L) | 1580 (974–2680) | 1660 (1130–2730) | 1300 (989–2240) | 0.33 |
Leukocyte count (×109/L) | 8.74 (6.53–10.7) | 8.31 (6.47–9.53) | 10.30 (7.57–12.30) | 0.06 |
IL-6 (pg/mL) | 161 (88–307) | 143 (91.5–246) | 197 (87.3–395) | 0.36 |
LDH (U/L) | 322 (271–394) | 320 (264–360) | 341 (293–456) | 0.06 |
NLR | 7.45 (4.78–10.7) | 6.72 (4.69–9.92) | 8.85 (5.03–12.40) | 0.22 |
PCT (ng/mL) | 0.97 (0.470–2.70) | 0.77 (0.36–2.04) | 1.44 (0.90–3.20) | 0.28 |
SOFA score | 7.00 (6.00–10.00) | 7.00 (6.00–8.00) | 11.00 (9.00–11.00) | <0.001 |
IMX-SEV-3b score * | 0.582 ± 0.13 | 0.575 ± 0.11 | 0.660 ± 0.15 | 0.050 |
CRP: C-reactive protein. LDH: lactate dehydrogenase. IL-6: interleukin-6. NLR: neutrophil-to-lymphocyte ratio. PCT: procalcitonin. SOFA: Sequential Organ Failure Assessment. * Mean ± SD; all others are reported as median (IQR).